secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivos Therapeutics, Inc. (VVOS)
CIK:        0001716166
Form:       8-K
Filed at:   2023-03-27T23:59:59+00:00
Accession:  0001493152-23-009006
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivos Therapeutics receives Nasdaq deficiency notice for bid price below $1.00 for 30 consecutive days
--------------------------------------------------------------------------------

- Received Nasdaq staff deficiency notice on March 24, 2023.
- Closing bid price below $1.00 for 30 consecutive business days (Feb 9 to Mar 23, 2023).
- Given 180-day compliance period until September 20, 2023 to regain compliance by closing at $1.00+ for 10 consecutive business days.
- If not compliant, may be eligible for additional 180-day grace period if meets other listing standards.
- Management intends to cure deficiency and continue listing on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716166/000149315223009006/0001493152-23-009006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716166/000149315223009006/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-009006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer